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Abstract
This study analyzed the distribution and prevalence of HIV-1 subtypes, multiplicity of HIV-1 infection, and frequency of inter-
subtype recombination among HIV-1-infected female bar and hotel workers in Moshi, Kilimanjaro Region, Tanzania, from
2004 to 2007. The HIV-1 viral sequences spanning the V1-C5 region of HIV-1 env gp120 were analyzed from 50 subjects by
single genome amplification and sequencing (SGA/S) technique. A total of 1740 sequences were amplified and sequenced
from the HIV-1 proviral DNA template. The median env sequences analyzed per subject per two time points was 38 (IQR 28–
50) over one year of HIV infection. In a subset of 14 subjects, a total of 239 sequences were obtained from HIV-1 RNA
template at the baseline visit. The most prevalent HIV-1 subtypes were A1 (56%) and C (30%), while HIV-1 subtype D and
inter-subtype recombinant viruses were found in 6% and 8% of subjects respectively. Transmission of multiple HIV-1
variants was evident in 27% of the subjects infected with pure HIV-1 subtypes A1, C, or D. The HIV-1 inter-subtype
recombinants were found in 8% including HIV-1 C/A, D/A, and complex mosaic recombinants. Multiple viral variants were
found in two subjects infected with inter-subtype recombinants. One subject harbored quasispecies of both pure HIV-1 A1
and C/A recombinant. The other subject was infected with two complex mosaic inter-subtype recombinant variants
belonging to subtype D. HIV-1 multiple infections and ongoing recombination contribute significantly to the genetic
diversity of circulating HIV-1 in Tanzania and have important implications for vaccine design and the development of
therapeutic strategies.
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Introduction
Based on phylogenetic inference, human immunodeficiency
virus type 1 (HIV-1) can be classified into four groups: main group
(M), outlier group (O), non-M-non-O group [1] and group P [2,3].
Group M accounts for the majority of HIV-1 infections globally
and is divided into nine genetic subtypes (A, B, C, D, F, G, H, J,
and K). However, HIV-1 subtypes A and C are the most prevalent
in the worldwide epidemic [4,5]. HIV-1 subtypes A and F are
further subdivided into sub-subtypes A1–A4 and F1–F2, respec-
tively [6]. Viruses from different lineages within group M
recombine and form recombinant viruses [1,7]. Currently, 51
circulating recombinant forms (CRFs) and a large number of
unique recombinant forms (URFs) have been described (see
http://www.hiv.lanl.gov), providing evidence for ongoing evolu-
tion of HIV-1 in the global epidemic [8].
Furthermore, individuals infected with multiple HIV-1 subtypes
[9–18], as well as individuals infected with multiple strains of the
same HIV-1 subtype have been reported [19–23], indicating that
the immune response generated against one strain or subtype of
HIV-1 does not necessarily protect against other HIV-1 strains or
subtypes [24–26].
HIV-1 infections with multiple viral variants and recombinant
viruses present a challenge for vaccine development and clinical
management. Multiple HIV-1 infections and recombinant viruses
have been associated with increased disease progression [27–29].
Individuals infected with a drug-sensitive virus may be super-
infected with a drug-resistant strain, severely hindering antiviral
treatment options [30].
Tanzania is one of the countries in sub-Saharan Africa that has
been most severely affected by the HIV epidemic. Several
molecular epidemiological studies have reported that HIV-1
subtypes A1, A2, C, D, G, CRF10_CD and other inter-subtype
recombinant viruses co-circulate in Tanzania [31–43]. Studies in
cohorts of female bar and hotel workers, a high-risk population of
HIV-1 infection in Moshi town, Kilimanjaro region, and in the
Mbeya region, reported HIV-1 prevalence rates of 26.3% [44]
and 67.8% [10], respectively, indicating that HIV-1 infection was
a major public health problem in this population. HIV-1 subtypes
A1, A2, C, D, CRF10_CD and other inter-subtype recombinant
viruses were reported among bar and hotel workers in Moshi town
[34,36]. The HIV-1 subtype profile was similar in the Mbeya
region with the exception of subtype A2 and CRF10_CD which
have not been found in the region [10]. Furthermore, HIV-1
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e47605multiple variants were reported in 23% of a high-risk population of
female bar and hotel workers with acute HIV-1 infection in the
Mbeya region of Tanzania [16].
It is likely that female commercial sex workers and their male
clients, as well as female bar and hotel workers, contribute
substantially to the rapid expansion of the HIV-1 epidemic in
developing countries [45,46] and may play an important role in
evolution facilitating multiple infections and recombination events
[10].
There is little information about multiplicity of HIV-1 infections
in regions like Tanzania where HIV-1 multiple subtypes and inter-
subtype recombinant viruses co-circulate.
This study focused on the molecular epidemiology of HIV-1
epidemic in female bar and hotel workers in Moshi town,
Kilimanjaro region, Tanzania. We determined the distribution
and prevalence of HIV-1 subtypes, multiplicity of HIV-1 infection,
and frequency of inter-subtype recombinant viruses in Tanzania.
We analyzed samples from a prospective cohort study of women at
increased risk of HIV-1 infection in Moshi town, Kilimanjaro
region of Tanzania. The objective of the study was to determine
factors associated with HIV-1 infection and describe the molecular
epidemiology of the HIV-1 epidemic over the course of the study.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki, and was approved by the
institutional review boards of the Kilimanjaro Christian Medical
Centre (KCMC), the Tanzania National Institute for Medical
Research, and the Harvard School of Public Health (HSPH). All
study subjects provided written informed consent for the collection
of samples and subsequent analysis.
Study subjects
Between December 2004 and March 2007, we recruited and
followed-up 800 women employed in the hotels, bars and guest
houses located in the study area. The age of the subjects at
enrollment ranged from 16 to 55 years old. All enrolled subjects
were females. Following baseline assessment, each subject was
evaluated quarterly for a period of one year. At each visit subjects
were examined and interviewed to obtain information about
sexual behaviors and HIV-related risk factors.
The HIV-1 infections were identified by using two diagnostic
HIV enzyme-linked immunosorbent assays (ELISA), Enzygnost
Anti HIV1/2 Plus (Dade Behring Liederbach, Germany) and
Vironostika HIV-Uni-form II plus (Organon, Boxtel, Nether-
lands). Indeterminate or discordant results were resolved by
Western blot test (Bio-Rad Laboratories Ltd, Dartford, UK).
Among 800 subjects, 139 (17%) were HIV-1 positive by
serological testing. Blood and genital samples were collected from
HIV-1 positive subjects at each visit. For this study, a subset of 50
subjects with samples available at baseline and 12 months were
selected. The mean age of selected subjects was 31.7 years old,
ranging from 21 to 53 years. The raw data for age, HIV-1 plasma
viral load, number of HIV-1 viral and proviral DNA sequences,
pairwise mean genetic distances and multiplicity of HIV-1
infection are shown in Table S1.
Single-genome amplification and sequencing (SGA/S)
Peripheral blood mononuclear cells (PBMCs) were isolated from
the whole blood by the ficoll-hypaque density gradient centrifu-
gation method, and stored in the liquid nitrogen. HIV-1 genomic
DNA was extracted from PBMCs by QIAamp DNA Blood Mini
Kit (QIAGEN) according to the manufacturer’s recommenda-
tions.
A fragment of HIV-1 env gp 120 spanning the V1–C5 region
(nucleotide position 6,615–7,757; HXB2 numbering; see http://
www.hiv.lanl.gov) was amplified using modified SGA/S technique
[47,48] based on the limiting dilutions method [49]. The template
was serially diluted and PCR amplified at each dilution. The
template dilution that produced approximately 30% of positive
amplicons was considered to be a dilution with a single amplifiable
molecule. Two time points, baseline and 12 months were targeted
in this study. The median env DNA sequences analyzed per subject
per two time points was 38 (IQR 28–50). First-round reaction was
conducted using primer pairs ED3 and ED14 [50]. PCR reactions
were performed in a volume of 20 ml and contained 1 mlo f
proviral DNA, 1.8 mM FastStart High Fidelity Buffer (Roche),
10 mM deoxynucleotide triphosphate (dNTPs (dATP, dCTP,
dGTP and dTTP)) Roche)), 10 pmol of each primer (Integrated
DNA Technologies) and 5U FastStart High Fidelity Enzyme
(Roche). The second round PCR reaction was done with primer
pairs ED5 and ED12 [50] 3 ml of first-round PCR product diluted
1:50 and 22 ml of master mix containing 1.8 mM FastStart High
Fidelity buffer, 10 mM dNTPs, 10 pmol of each primer and 5 U
FastStart High Fidelity Enzyme. Thermal cycling conditions for
both reactions were: 95uC for 2 minutes, followed by 3cycles at
95uC for 1 min, 57uC for 1 min, and 72uC for 2 min followed up
by 37 cycles of 95uC for 15 sec, 57uC for 45 sec and 72uC for
1 min, with a final extension step at 72uC for 7 min. Reaction
mixtures were stored at 4uC until use.
RNA isolation, reverse transcriptase polymerase chain
reaction (RT-PCR) and SGA/S
We identified 14 out of 50 subjects infected with HIV-1 multiple
variants. To exclude potential laboratory contamination, the
alternative amplification template, the viral RNA from plasma,
was used in a subset of 14 subjects. HIV-1 viral RNA was isolated
from plasma sample by QIAamp viral RNA Mini Kit (QIAGEN,
Valencia, CA) according to the manufacturer’s recommendations.
The cDNA synthesis was performed using the Transcriptor First
Strand cDNA Synthesis Kit (Roche Diagnostics GmbH, Man-
nhein, Germany). Viral RNA, 10 pmol of OFM19 primer
(nucleotides 9,604 to 9,632; HXB2 numbering) and nuclease-free
water were incubated at 65uC for 10 min to denature the
secondary structure of the RNA. The cDNA synthesis was
performed in a volume of 20 ml containing denatured viral
RNA, 8 mM reverse transcriptase buffer, 20 U RNase Inhibitor,
10 mM dNTPs, and 10 U transcriptor reverse transcriptase
enzyme. The reverse transcriptase reaction was incubated at
55uC for 30 min followed by heating at 85uC for 5 min to
inactivate the enzyme. The cDNA samples were stored at 280uC
until use.
The cDNA synthesized from the viral RNA template was
amplified by the SGA/S technique similar to PCR amplification of
proviral DNA. First-round PCR reactions were conducted using
primer pairs OFM19 and VIF1 (59-GGG TTT ATT ACA GGG
ACA GCA GAG-39) (nucleotides 4,900 to 4,923; HXB2
numbering). PCR reactions were performed in a volume of
22 ml containing 1 ml of cDNA, 1.8 mM FastStart High Fidelity
buffer, 10 mM dNTPs, 10 pmol of each primer and 5 U FastStart
High Fidelity Enzyme. The first PCR condition consisted of 95uC
for 2 minutes, followed by 35 cycles of 95uC for 15 sec, 57uC for
30 sec, 68uC for 4 min and extension step 68uC. The second
round PCR reaction was done with primer pairs ED5 and ED12.
Three ml of first-round PCR product diluted 1:20 were added to
22 ml of master mix containing 1.8 mM FastStart High Fidelity
HIV-1 Subtypes in Northern Tanzania
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High Fidelity Enzyme. The second round PCR was performed at
95uC for 2 min, followed by 35 cycles of 95uC for 20 sec, 60uC for
30 sec, 72uC for 2 min, followed by final extension step at 72uC
for 7 min. Reaction mixtures were stored at 4uC until use.
Amplified products from both proviral DNA and viral RNA
were electrophoretically analyzed by applying 5 ml of second PCR
amplification product to 1% agarose gel containing ethidium
bromide, and visualized under ultraviolet light. Amplicons were
purified by Exo-Sap [51] and directly sequenced on both strands
on the ABI 3730 DNA analyzer using the BigDye technology.
Phylogenetic analysis
Generated HIV-1 proviral DNA and viral RNA sequences of
the gp 120 env V1–C5 region were assembled and edited using
SeqScape V 2.6. The sequences were aligned together with the
HIV-1 reference subtype sequences retrieved from the Los Alamos
HIV-1 Sequence Database at http://www.hiv.lanl.gov using
muscle algorithm in MEGA 5.0 [52] with minor manual
adjustment in BioEdit version 7.0 [53]. Maximum likelihood
(ML) phylogenetic trees were constructed by PhyML version 3.0.1
[54] and visualized by FigTree v1.3.1 [55]. The approximate
likelihood ratio test (aLRT) was used as a statistical test for support
of splits [56]. aLRT values $0.95 were considered significant and
are displayed at the tree nodes. Additionally, the neighbor-joining
(NJ) trees were constructed by MEGA 5.0 using the Kimura-two
parameter model for pairwise distance calculations with 1000
bootsrap replicates [57]. The bootstrap values $80% were
considered significant [58]. HIV-1 subtypes were determined
based on branching topology, clustering and splits support of the
analyzed sequences and their phylogenetic relationships with HIV-
1 reference subtype sequences from the Los Alamos HIV-1
Sequence Database.
The DNA sequences were analyzed for evidence of APO-
BEG3G induced hypermutation by using Hypermut tool V2.0
[59]. Sequences with a P value of #0.05 were considered enriched
for mutations consistent with APOBEG3G signatures and were
excluded from analysis.
Multiplicity of HIV-1 infection
In order to distinguish HIV-1 infections with single and multiple
viral variants, phylogenetic analysis was performed within the
subset of subjects with HIV-1 subtype A1 (n=27), subtype C
(n=15) and subtype D (n=3). Four subjects were infected with
inter-subtype recombinant viruses and therefore excluded from
this analysis. (Note that 28 subjects were infected with subtype A1;
however, one (code 181) out of 28 subjects had one DNA sequence
and was excluded in this analysis).
Decision on multiplicity of HIV-1 infection was made based on
branching topology and clustering of analyzed viral quasispecies.
The HIV-1 single variant was defined as an infection of the same
HIV-1 subtype in which the viral quasispecies form a distinct
phylogenetic cluster with an aLRT support value $0.95 in ML
analysis, and/or a bootstrap value $80% in NJ analysis. The
HIV-1 multiple variant was defined as an infection resulting from
more than one variant of the same or different HIV-1 subtypes in
which the viral quasispecies formed more than one distinct cluster
each supported with an aLRT support value $0.95 in ML
analysis, and/or a bootstrap value $80% in NJ analysis. Mean
pairwise genetic distances between the clusters were computed for
subjects infected with multiple HIV-1 variants.
Nucleotide differences were visualized by the highlighter tool
from the Los Alamos HIV-1 Sequence Database website by
comparing the HIV-1 proviral DNA and viral RNA sequences to
the consensus of the earliest sequences created in BioEdit.
Screening for inter-subtype recombination and
breakpoints identification
All DNA sequences (n=1979) generated in this study were
screened for evidence of inter-subtype recombination by the
Recombination Identification Program (RIP 3.0) [60] and the
REGA HIV-1 Subtyping Tool-Version 2.0 [61]. The identified
recombinant viruses were further analyzed for subtype assignment
and breakpoints identification by SimPlot software v3.5.1 [62].
The bootscanning method in SimPlot was parameterized with
sliding window size of 350 bp, step increment 3 bp, and Kimura
2-parameter distance model for inferring phylogenetic trees by the
NJ method. HIV-1 reference subtype sequences retrieved from the
Los Alamos HIV Sequence Database were used. Identified
breakpoints were visually inspected in BioEdit. To confirm the
HIV-1 subtypes in the inter-subtype recombinant viruses, nucle-
otide sequences on both sides of the breakpoint were analyzed
independently by re-constructing phylogenetic trees using the splits
at the putatively identified breakpoints.
HIV-1 RNA load from Plasma
For each subject, the HIV-1 plasma RNA viral load was
quantified by the Roche Amplicor HIV-1 Monitor test, version 1.5
assay as recommended by manufacturer (Roche Molecular
Systerms) at the baseline and the 12 month visits.
Viral diversity
Mean pairwise genetic distances were computed between
baseline and 12 month visits using MEGA software V 5.0.
Multiple viral quasispecies were available at two visits in 24 of 27
subjects with subtype A1, and 14 of 15 subjects with HIV-1
subtype C. For subtype D and inter-subtype recombinants the
mean pairwise genetic distances were calculated in three and four
subjects, respectively.
Control for cross-contamination
To confirm that the HIV-1 multiple variants reported in this
study were not due to laboratory cross-contamination during
specimen collection, processing, amplification, and/or sequencing,
the following strategies were practiced consistently during the
experimental work: (1) viral RNA plasma was used as an
alternative template (n=14); (2) sample from an alternative study
visit was amplified and sequenced; (3) nucleic acid isolation and
different steps of PCR procedures were separated by place and
time; and (4) proper quality controls were included at each step.
Statistical analysis
Descriptive statistics were quantified using Sigma Stat v.3.5.
Comparisons of continuous outcomes between two groups were
based on the Mann-Whitney Rank Sum test. The bootstrap and
aLTR support values for splits in the inferred phylogenetic trees
were computed by MEGA 5.0 and PhyML respectively. All
reported p-values are 2-sided and not adjusted for multiple
comparisons.
Accession numbers
All generated sequences were submitted to GenBank. The
accession numbers are JX070938–JX072916.
HIV-1 Subtypes in Northern Tanzania
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Phylogenetic relationship and subtype distribution
A fragment of HIV-1 genome encompassing the V1-C5 region
of env gp120 was analyzed by SGA/S technique in 50 subjects. A
total of 1,740 viral sequences were amplified and sequenced from
proviral DNA. The median number of env sequences analyzed per
subject per two time points was 38 (IQR 28–50). In a subset of 14
subjects, a total of 239 sequences were obtained from HIV-1 RNA
template at the baseline visit. In four subjects (codes 181, 321, 404,
and 405) samples could only be amplified at the 12 month visit,
while in one subject (code 740) only the baseline sample was
successfully amplified (Table S1).
The HIV-1 subtyping of viral sequences generated in this study
was performed by alignment with HIV-1 reference subtypes (A, B,
C, D, F, G, H, J and K) from the Los Alamos HIV-1 Sequence
Database, and phylogenetic analysis by Maximum Likelihood
(ML) method implemented in FastTree 2 [63]. Viral sequences
from 28 subjects clustered with HIV-1 subtype A1 references
(aLRT support of 1.0), viral sequences from 15 subjects clustered
with HIV-1 subtype C references (aLRT support of 1.0), and viral
sequences from three subjects clustered with HIV-1 subtype D
references (aLRT support of 1.0) (data not shown). 183 HIV-1
DNA recombinant sequences (inter-subtype) from four subjects
were analyzed separately (see below).
For clarity of presentation, ten proviral DNA sequences per
subject were selected and analyzed for HIV-1 subtyping. This
subset included the first five sequences from the baseline visit and
the first five sequences from the 12 month visit. For the subjects
with less than five sequences, all available sequences were included
(n=7). If viral sequences were available at one time point (n=5)
only, ten sequences were selected and included in the analysis. In
addition, from 14 subjects with viral sequences obtained from
HIV-1 RNA template at the baseline visit, the first five sequences
were selected and included in the HIV-1 subtyping analysis. The
phylogenetic inference using the ML method (Fig. 1) revealed that
the most prevalent HIV-1 subtype was A1 (56%), followed by
subtype C (30%). HIV-1 subtype D and inter-subtype recombi-
nant viruses were less prevalent (6% and 8% respectively). The
distribution of HIV-1 subtypes among study subjects is summa-
rized in Table 1.
Multiplicity of HIV-1 infection
In order to determine HIV-1 infection with multiple variants of
the same subtype, phylogenetic analysis was performed within the
subsets of individuals infected with HIV-1 subtype A1 (n=27) and
subtype C (n=15). The inferred ML phylogenetic trees helped to
determine that single HIV-1 variants were found in 33 (73.3%)
subjects (an example is shown in Fig. S1), while multiple HIV-1
variants were evident in 12 (26.7%) subjects. In HIV-1 subtype
A1, nine of 27 (33%) subjects had HIV-1 multiple variants
(Table 2). Two distinct phylogenetic lineages (mean pairwise
distance between clusters of 18%; aLRT support 1.0, Fig. 2) were
observed for subject 20, suggesting infection with two unrelated
variants of HIV-1 subtype A1. Similarly, two distinct clusters
(mean pairwise distance between clusters 19.6%) were observed
for subject 87, suggesting that this subject was also infected with
two unrelated variants of HIV-1 subtype A1 (data not shown). The
DNA sequences of the other seven subjects formed multiple
distinct clusters with significant aLRT support values and mean
pairwise distances from 6.4% to 12.4%, indicating uncertainty in
relation to transmission of unrelated, or closely related viral
variants. An example of infection with two closely related variants
of HIV-1 subtype A1 is shown in Fig. 2.
Phylogenetic analysis of HIV-1 subtype C sequences from 15
subjects indicated that three subjects (20%) had HIV-1 multiple
variants. Viral sequences in subjects 171 and 291 formed two
distinct phylogenetic lineages with mean pairwise distances
between two clusters of 16.3% and 20.6%, respectively, and a
high aLRT support value (Fig. 3), indicating multiple HIV-1
subtype C infections. The viral sequences from subject 201 formed
two distinct clusters, each with a significant aLRT support value,
but the mean pairwise distance between two clusters was 11.4%,
indicating uncertainty in relation to transmission of unrelated, or
closely related, HIV-1 subtype C variants. An example of infection
with closely related HIV-1 subtype C variants is shown in Fig. 3.
None of the subjects with pure HIV-1 subtype D were infected
with multiple variants (Table 2).
A potential transmission cluster
Within the analyzed set of viral sequences we found a potential
transmission cluster evident from branching topology and aLRT
support of quasispecies belonging to subjects 322 and 87 (aLRT
support 1.0; Fig. 2). This observation indicates a potential
epidemiological link due to a common source of infection or
existence of a larger HIV-1 transmission cluster. To confirm that
the clustering was not due to laboratory cross-contamination, the
cDNA sequences from the baseline visit of subject 322 were also
included in the analysis. Results showed that four cDNA sequences
and nine DNA sequences from subject 322 clustered together with
36 sequences from subject 87. Taken together, these results suggest
no laboratory cross-contamination.
Inter-subtype recombinant viruses
All viral DNA sequences generated in this study were analyzed
for evidence of inter-subtype recombination by the recombination
identification program (RIP 3.0; http://www.hiv.lanl.gov), and
REGA HIV-1 subtyping tool (http://dbpartners.stanford.edu/
RegaSubtyping/). The inter- subtype recombinant viruses were
confirmed by bootscanning analysis using SimPlot v3.5.1 [62].
HIV-1 inter-subtype recombinant viruses were found and
analyzed in greater detail in four (8%) out of 50 subjects
(Table 3). In three subjects, 33, 471, and 510, all viral quasispecies
were represented by inter-subtype recombinant viruses, while
subject 322 had both pure HIV-1 subtype A1 and inter-subtype
recombinant viruses. All 48 sequences of subject 33 were classified
as inter-subtype recombinant viruses of HIV-1 subtype D/A with
a similar breakpoint at position 7,483 (HXB2 numbering). HIV-1
viral sequences of subject 471 (n=50) were classified as C/A1
inter-subtype recombinant viruses with a similar breakpoint at
position 7,085 (HXB2 numbering). In subject 322, 13 of 41 viral
quasispecies were pure HIV-1 subtype A, while the remaining 28
sequences were represented by HIV-1 C/A recombinant with a
breakpoint located at position 6,881 (HXB2 numbering). To
determine relationships between the non-recombinant subtype A
and the A fragment in C/A recombinant sequences, the sub-
region at position 6,881–7,745 (HXB2 numbering) was phyloge-
netically analyzed. We found that 13 non-recombinant HIV-1 A
sequences clustered separately from the subtype A1 fragment from
HIV-1 C/A recombinant virus (data not shown).
The SimPlot analysis of viral sequences in subject 510 showed
that 56 of 57 sequences were comprised of HIV-1 subtype D and
unclassified regions (U) (Fig. 4A). One out of 57 sequences
included the subtype A-like insertion on the backbone of HIV-1
subtype D (nucleotides position 7,346 to 7,500; HXB2 number-
ing), however, the bootstrap support for the insertion was not
sufficient for assignment to HIV-1 subtype A1 (Fig. 5A).
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sequences in subject 510, the ML trees were generated separately
for two regions, 6,615 to 7,226 (HXB2 numbering) and 7,227 to
7,745 (HXB2 numbering; Fig. 4B & C). Results showed that the
first analyzed fragment clustered with HIV-1 subtype D references
(Fig. 4B; aLRT support of 0.98). However, the second fragment
did not cluster with any subtype (Fig. 4C), and can be considered
as an unclassified region. Similar branching topology and
bootstrap support were observed in phylogenetic trees inferred
by the neighbor-joining (NJ) method (data not shown).
To clarify the recombination patterns in the DNA sequence of
subject 510 that included the subtype A-like insertion on the
background of HIV-1 subtype D, the ML phylogenetic trees were
inferred for three fragments of this sequence. As expected, the
SimPlot results (Fig. 5A) were confirmed by phylogenetic inference
Figure 1. A maximum likelihood (ML) phylogenetic tree of HIV-1 env gp 120 V1-C5 sequences from 50 subjects. The ML tree was
constructed by PhyML 3.0.1 and visualized in FigTree. HIV-1 group N sequence was used as an outgroup. A representative subset of 516 out of 1796
DNA sequences generated in this study is presented in the Figure. Ten DNA sequences representative of each sample were chosen and analyzed with
HIV-1 reference subtypes from the Los Alamos HIV Sequence Database. The inter-subtype recombinant DNA sequences were excluded in this Figure.
Reference subtypes A1, C, D are shown in red, pink, and blue respectively. The other reference subtypes are shown in orange. The approximate
likelihood ratio test (aLRT) values of $0.95 were considered significant and are shown by an asterisk (*). Scale at the bottom of the Figure
corresponds to 0.01 nucleotide substitutions per site.
doi:10.1371/journal.pone.0047605.g001
Table 1. Distribution of HIV-1 env V1-C5 subtypes among
female bar and hotel workers in Moshi, Kilimanjaro region,
Tanzania, during 2004–2007.
HIV-1 subtype Study subjects, (%)
A1 28 (56%)
C 15 (30%)
D 3 (6%)
Inter-subtype recombinants 4 (8%)
Total 50 (100%)
doi:10.1371/journal.pone.0047605.t001
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PLOS ONE | www.plosone.org 5 October 2012 | Volume 7 | Issue 10 | e47605Figure 2. A maximum likelihood phylogenetic tree of HIV-1 env gp 120 V1-C5 sequences from 29 subjects infected with HIV-1
subtype A is presented. (Note that 13 DNA sequences classified as pure subtype A1 from subject 322 were also included in this analysis, resulting
in a total of 29 subjects). Subject 20 was infected with two distinct unrelated variants of HIV-1 subtype A1 which are shown in red. Subject 168
infected with two closely related variants of subtype A1 which are shown in light blue and highlighter plot. The DNA sequences of subject 87 shown
in blue clustered with the DNA sequences of subject 322 shown in purple with the aLRT support value of 1.0. Methodological details have been
described in the legend to Figure 1. Scale at the bottom of the Figure corresponds to 0.01 nucleotide substitutions per site.
doi:10.1371/journal.pone.0047605.g002
Table 2. HIV-1 single and multiple variants of the same subtype among female bar and hotel workers in Moshi, Kilimanjaro region,
Tanzania.
HIV-1 subtypes Subjects, n HIV-1 infection with single variant HIV-1 infection with multiple variants
A1 27 18 (67%) 9 (33%)
C 15 12 (80%) 3 (20%)
D 3 3 (100%) 0 (0.0%)
Total 45 33 (73.3%) 12 (26.7%)
*A subset of 45 samples with pure subtypes (A1, C or D) was analyzed for multiple infections; sample 181 was excluded due to a single available DNA sequence.
doi:10.1371/journal.pone.0047605.t002
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position 7,346 to 7,500; HXB2 numbering) that was close to A1
had an aLRT support of 0.81 which made its assignment with
HIV-1 subtype A1 uncertain (Fig. 5C). The third fragment
clustered with HIV-1 subtype D with an aLRT support of 0.87
potentially indicating a diversified subtype D variant (Fig. 5D).
The low aLRT support value for the second and the third
fragments could possibly be due to their short length and limited
number of informative sites. Phylogenetic analysis by NJ method
showed similar branching topology (data not shown). Therefore,
we concluded that subject 510 was infected with two complex
mosaic inter-subtype recombinant viruses; one recombinant
comprised of subtype D and unclassified regions (U), while the
other recombinant included the HIV-1 subtype A-like insertion on
the background of HIV-1 subtype D. The subtype A-like fragment
was considered to be unclassified region (U).
Figure 3. A maximum likelihood phylogenetic tree of HIV-1 env gp 120 V1-C5 sequences from 15 subjects infected with subtype C.
Subjects 171 and 291 were infected with two unrelated HIV-1 variants of subtype C which are shown in green and pink respectively. Subject 201
infected with two closely related variants of subtype C which are shown in red and highlighter plot. Methodological details have been described in
the legend to Figure 1. Scale at the bottom of the Figure corresponds to 0.01 nucleotide substitutions per site.
doi:10.1371/journal.pone.0047605.g003
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The HIV-1 RNA load in plasma was quantified in all subjects at
both the baseline and the 12 month visits by the Roche Amplicor
HIV-1 Monitor test, version 1.5 assays. Undetectable levels of
HIV-1 RNA were found in one subject at the baseline visit and in
ten subjects at the 12 month visit (Table S1). Information about
anti-retroviral treatment (ART) status was not collected in this
study. Therefore it is possible that at least some subjects started
ART during the study. The undetectable levels of HIV-1 RNA at
12 month visit support initiation of ART. We addressed whether
HIV-1 RNA load in plasma differs between HIV-1 subtypes A, C,
D, and inter-subtype recombinant viruses. We found no statisti-
cally significant difference in the levels of HIV-1 RNA load
between subtypes at two time points (Table S2). High HIV-1 RNA
plasma viral load was observed in some of the subjects with
multiple HIV-1 subtype A1 infections at both the baseline and the
12 month visits but the difference was not statistically significant
(data not shown).
Viral diversity
Mean pairwise genetic distances within subsets of subjects
infected with HIV-1 subtypes A, C, D and inter-subtype
recombinant viruses were calculated at two time points over the
follow-up period of one year. Changes in mean pairwise distances
were not statistically significant over the observed period of time,
apparently due to high heterogeneity among subjects and
relatively small sample size (Fig. S2). The mean pairwise genetic
distance of viral sequences in HIV-1 subtype A1 changed from
3.962.3 and 4.662.4 (P=0.26), in HIV-1 subtype C from
5.062.9 and 4.962.4 (P=0.88), in HIV-1 subtype D from
2.560.5 and 3.460.6 (P=0.09), and in recombinant viruses from
5.363.5 and 6.463.6 (P=0.68) (Table S3). 22 (92%) of 24
subjects infected with HIV-1 subtype A1, eleven (79%) of 14
subjects infected with HIV-1subtype C, all three subjects infected
with HIV-1 subtype D, and three of four subjects infected with
recombinant viruses showed an increase of mean pairwise genetic
distances over time. However, there was a significant decrease in
the mean pairwise genetic distances of one subject infected with
HIV-1 subtype C at the 12 month visit, which may be due to a
small number of viral sequences being analyzed (Fig. S2). The
overall mean pairwise genetic distances are shown in Table S3.
These results indicated that there was no statistical significant
difference in mean pairwise genetic distances between the baseline
and the 12 month visits for HIV-1 subtypes A1, C, D, and inter-
subtype recombinant viruses. We found a wide range of variation
of mean viral diversity between subjects from 0.1% to 11.3%.
Discussion
This study assessed the distribution and prevalence of HIV-1
subtypes, multiplicity of HIV-1 infection, and provided evidence of
inter-subtype recombination among female bar and hotel workers,
one of the highest risk populations in Tanzania.
The most prevalent HIV-1 subtype was subtype A1 (56%),
followed by subtype C (30%), while HIV-1 subtype D (6%) and
inter-subtype recombinant viruses (8%) were less frequent. These
results are consistent with the previous studies conducted in
Tanzania [36,38] and suggest that HIV-1 subtype A1 still
predominates while HIV-1 subtype C continues to spread in this
population.
Previous studies from Tanzania, using small sample sizes,
reported a predominance of HIV-1 subtype D in the mid-1990s
[33,42], while later studies found a higher frequency of HIV-1
subtype A1 [39,64]. The fact that individuals infected with HIV-1
subtype D develop AIDS and die sooner than those infected with
subtype A1 [65,66] could partially explain the decreased
prevalence of HIV-1 subtype D in this population. Additionally,
it is also possible that HIV-1 subtype D has lower transmission
efficiency.
Multiple HIV-1 infections have been reported in previous
studies [19,23,28,67–69] including in the Mbeya region that
reported multiple HIV-1 infections in 19.9% of HIV-1 infected in
a high-risk sexual behavior population (female bar and hotel
workers) [10]. In this study we identified 12 subjects (27%) with
multiple HIV-1 infections including distinct and closely related
viral variants. It was not clear whether subjects infected with
closely related HIV-1 variants were superinfected. The mean
pairwise distances between each subject’s clusters were too high for
the intra-patient diversity but too low for the inter-patient level of
diversity. Due to limitations of the study design, for subjects
identified with closely related viral variants, we cannot exclude (1)
long history of HIV infection, (2) transmission of multiple viral
variants from the same partner with chronic infection (e.g., on
multiple occasions), or (3) superinfection with closely related viral
variants circulating within the same transmission network. HIV-1
infection with multiple variants dramatically increases the overall
diversity and may lead to recombinant viral variants within a short
period of time. It is likely that multiple viral variants might
contribute to fast exhaustion of immune response and a reduced
capacity of the immune system to contain viral replication [70].
Table 3. Inter-subtype recombinant viruses distribution among female bar and hotel workers in Moshi, Kilimanjaro region,
Tanzania, during 2004–2007.
Subject’s ID
Proviral DNA
sequences, n
Viral cDNA
sequences, n
HIV-1 inter-subtype
recombinants
SimPlot bootscan breakpoint
position*
33 47 1 D/A 7,483
322 9 4 A
23 5 C/A 6,881
471 50 NA C/A 7,085
510 47 9 D/U
1 7,226
1N A D / U
1/D 7,346: 7,500
1Unclassified region.
NA: not available.
*Numbering positions relative to HIV HXB2.
doi:10.1371/journal.pone.0047605.t003
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been associated with faster disease progression [18,27–29] and
might lower the likelihood of successful anti-retroviral therapy if
multiple infections are caused by both susceptible and drug
resistant strains [30].
The epidemiologically linked viruses in subjects 87 and 322
were evident by branching topology and a significant aLRT
Figure 4. Maximum likelihood phylogenetic trees for two fragments of the 56 out of 57 viral quasispecies for subject 510 as
identified by SimPlot analysis. Fig. 4A: In subject 510, the majority (56 of 57) of viral quasispecies were comprised of subtype D (light blue bar)
and unclassified regions (back bar). A breakpoint is located at position 7,226 (HXB2 numbering). Bootscanning was performed on the alignment by
SimPlot v 3.5.1 using Kimura 2-parameter model with sliding window size 350 bp and step increment 3 bp and Kimura 2-parameter distance model.
A bootstrap value $80% was considered significant. Bootstrap values are indicated on the y axis and nucleotide positions in the alignment are shown
on the x axis. Figs. 4B & 4C: Phylogenetic analysis (ML trees) of two fragments identified by the breakpoint located at position 7,226 (HXB2
numbering). After SimPlot analysis the breakpoint was visualized in the alignment by BioEdit. Fig. 4B is a ML tree of the fragment classified as HIV-1
subtype D and Fig. 4C is a ML tree of the unclassified fragment whose subtype classification was unresolved by bootscan analysis. The unclassified
region clustered with none of the HIV-1 reference subtypes from the Los Alamos HIV Sequence Database. The viral quasispecies of subject 510 are
shown in light blue, and the legend at the right of the bootscan plot indicates reference HIV-1 subtypes. The aLRT values $0.95 were considered
significant and are shown by asterisk (*). Selected aLRT values are shown at the branch node of the tree. Scale at the bottom of the Figure
corresponds to 0.1 nucleotide substitutions per site.
doi:10.1371/journal.pone.0047605.g004
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from a common source or represent an HIV-1 transmission chain
in this community [44,46]. Similar results were reported
previously in five bar and hotel workers who were infected with
HIV-1 subtype A1 and clustered together with a significant
bootstrap support, suggesting some epidemiological link among
the subjects [36].
In this study four of the 50 subjects were infected with inter-
subtype recombinant viruses (one case of D/A, two cases of C/A,
and one case had two complex mosaic recombinants). The later
had one virus comprised of HIV-1 subtype D and unclassified
regions that did not cluster with any known HIV-1 group M
subtypes. The second virus had an insertion of unclassified region
in the background of subtype D. These findings reveal the ongoing
recombination of circulating HIV-1 strains which resulted in
complex mosaic recombinants.
Viral quasispecies in one subject (322) included HIV-1 subtype
A and C/A recombinant providing evidence for a multiple
infection. Phylogenetic analyses demonstrated a substantial
difference between HIV-1 subtype A sequences and the A
fragment in the C/A recombinant, suggesting different origins of
non-recombinant and recombinant HIV-1 subtype A in this
subject. The available sample did not resolve whether this subject
was infected by multiple HIV-1 variants, or contracted a super-
infection.
Figure 5. Maximum likelihood phylogenetic trees for three fragments of the one out of 57 viral quasispecies for subject 510 as
identified by SimPlot analysis. Fig 5A: A single viral sequence in subject 510 with distinct recombination pattern, D/U/D. The bootscan plot was
generated by Simplot. HIV-1 subtype D is shown in the blue bar and unclassified region is shown in the black bar. Figs. 5B, 5C & 5D: Maximum
likelihood (ML) trees of three fragments classified as subtype D (nucleotide position 6,615 to 7,345, Fig. 5B), unclassified fragment (nucleotide position
7,346 to 7,500, Fig. 5C) and fragment classified as subtype D (nucleotide position 7,501 to 7,745). The viral quasispecies were analyzed with reference
sequences from the Los Alamos HIV Sequence Database. The first fragment clustered with subtype D with a high aLRT support value (shown in light
blue square), the second fragment clustered with subtype A1 but aLRT was insufficient (0.81; shown in black square). The third fragment clustered
with subtype D with a weak aLRT support (0.87). Scale at the bottom of the Figure corresponds to 0.1 nucleotide substitutions per site.
doi:10.1371/journal.pone.0047605.g005
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and shared no recombination patterns and/or breakpoints
suggesting evidence for ongoing recombination among circulating
viruses in Tanzania, and emergence of unique recombinant forms
(URFs). URFs of HIV-1 with different recombination patterns
have been reported previously in Tanzania [10,16,36,38,71]. No
viral sequences closely related to the HIV-1 CRF10_CD reported
previously in Tanzania [34,37,38] have been found in this study,
suggesting no selective advantage of CRF10_CD in this popula-
tion.
The prevalence of inter-subtype recombinant viruses in this
study was lower than in the previous study from Tanzania [36].
To address the observed difference in frequency of inter-subtype
recombinants, we applied current analytical methods to HIV-1
sequences from the previous study. Only two of seven sequences
reported as recombinants [36] showed evidence for inter-subtype
recombination suggesting high sensitivity of recombination anal-
ysis to the analytical method used (Table S4). The lower
prevalence of inter-subtype recombinants can be explained by at
least three reasons. Firstly, the use of SGA/S approach minimizes
in vitro viral recombination resulting from Taq polymerase-
mediated template switching [47,48]. Secondly, the analysis of
only one region of the HIV-1 genome (env V1-C5) may
underestimate the true proportion of recombinant viruses in this
population. Lastly, if some of the recombinants are transient with
low levels of replication, then the recombinants could likely go
undetected [72]. It has been described that about 10% of the HIV-
1 isolates sequenced over large regions including several genes are
inter-subtype recombinants [73]. Thus, including multiple regions
of the HIV-1 genome or the full HIV-1 genome may provide a
better estimate of recombinant viruses [69].
Analysis of the HIV-1 RNA levels in plasma revealed no
statistical difference between HIV-1 subtypes in this study. A high
HIV-1 plasma viral load was observed in some of the subjects who
had HIV-1 multiple infections and recombinant viruses. However,
these findings could not be statistically corroborated because of
small sample size. Similarly, changes in mean pairwise genetic
distances were not statistically significant over the observed period
of time, apparently due to high heterogeneity among subjects,
relatively small sample size and the short duration of the follow-up
period.
This study has limitations. Firstly, the analysis of one region of
the HIV-1 genome (env V1-C5 of gp 120) may underestimate the
true proportion of HIV-1 subtypes, recombinants and multiplicity
of HIV-1 infections. Secondly, the duration of HIV-1 infection
was unknown. The study had no power to determine whether the
multiplicity of the HIV-1 infections were due to co-infections,
super-infections or both. Thirdly, some of the subjects had
undetectable plasma HIV-1 viral RNA although they tested
HIV-1 positive by antibodies tests. It is likely that the undetectable
HIV-1 RNA was associated with the low number of the amplified
viral quasispecies in some of the subjects, or resulted in negative
amplification. The primers mismatch can also attributable in few
cases of PCR failure. In addition, we cannot exclude the possibility
that some subjects may have been receiving antiretroviral
treatment at the time of sample collection without our knowledge.
Therefore, further studies with large sample sizes using multiple
regions of the HIV-1 genome or the full HIV-1 genome will be
necessary to elaborate the prevalence of multiple HIV-1 infections
as well as inter-subtype recombination in this population.
In summary, this study demonstrated that HIV-1 subtype A1 is
still the most prevalent subtype followed by HIV-1 subtype C. We
also reported for the first time a high prevalence HIV-1 infection
with multiple variants in this population in Moshi, Tanzania. Our
results suggest that individuals infected with multiple viral variants
might contribute to increased HIV-1 diversity through generation
of complex recombinant viruses which pose a challenge to the
design and development of HIV-1 vaccines, diagnostics and
antiretroviral therapy.
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